Home Podcasts BJD Talks
BJD Talks

BJD Talks

BJD 45 episodes Oct 23, 2026

The official podcast of the British Journal of Dermatology, covering topics in dermatology research and clinical practice.

Episodes

Episode 55 - Keratinocyte cancer trends in England 2013–2022
Episode 55 - Keratinocyte cancer trends in England 2013–2022 Oct 23, 2026 4:31 In this episode of BJD Talks, Sam and Meera discuss the article ‘Trends in keratinocyte cancers in England, 2013–22: basal cell carcinoma incidence, cutaneous squamous cell carcinoma incidence and nonmelanoma skin cancer mortality’ by Mistry et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag315 *This podcast was generated by an AI tool created by 67Bricks for the British A
Episode 54 - Subcutaneous efgartigimod in pemphigus: phase III ADDRESS trial
Episode 54 - Subcutaneous efgartigimod in pemphigus: phase III ADDRESS trial Oct 23, 2026 4:22 In this episode of BJD Talks, Sam and Meera discuss the article ‘Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial’ by Joly et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag199 *This podcast was generated by an AI tool created by 67Bricks for the Britis
Episode 53 - Scaffold delivery of basement membrane motifs for wound healing
Episode 53 - Scaffold delivery of basement membrane motifs for wound healing Oct 7, 2026 4:18 In this episode of BJD Talks, Sam and Meera discuss the article ‘Engineered Caf1 constructs encoding laminin-332 motifs: a novel approach for enhanced cutaneous wound healing’ by Nie et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag235 *This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*
Episode 52 - Durability of icotrokinra response through week 52
Episode 52 - Durability of icotrokinra response through week 52 Oct 5, 2026 4:27 In this episode of BJD Talks, Sam and Meera discuss the article ‘Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials ’ by Stein Gold et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag264 *This podcast was generated
Episode 51 - Skin cancer mortality in Australian and New Zealand kidney transplant recipients
Episode 51 - Skin cancer mortality in Australian and New Zealand kidney transplant recipients Oct 2, 2026 4:40 In this episode of BJD Talks, Sam and Meera discuss the article ‘Skin cancer mortality in Australian and New Zealand kidney transplant recipients: a population-based cohort study using linked health data, 1990–2019 ’ by Forcey et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag232 *This podcast was generated by an AI tool created by 67Bricks for the British Association of D
Episode 50 - Reducing infant bathing: a randomized controlled feasibility trial
Episode 50 - Reducing infant bathing: a randomized controlled feasibility trial Sep 28, 2026 3:20 In this episode of BJD Talks, Sam and Meera discuss the article ‘Randomized controlled feasibility trial of an intervention to reduce infant bathing’ by Perkin et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag248 *This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*
Episode 49 - Quality of life in patients with BCNS
Episode 49 - Quality of life in patients with BCNS Aug 21, 2026 4:21 In this episode of BJD Talks, Sam and Meera discuss the article ‘Health-related quality of life in patients with basal cell naevus syndrome and high-frequency basal cell carcinoma: a questionnaire study’ by Massella Patsea et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag212 *This podcast was generated by an AI tool created by 67Bricks for the British Association of Derma
Episode 48 - Deucravacitinib in patients with alopecia areata in a phase II trial
Episode 48 - Deucravacitinib in patients with alopecia areata in a phase II trial Aug 4, 2026 3:26 In this episode of BJD Talks, Sam and Meera discuss the article ‘Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicentre, randomized, double-blinded, placebo-controlled trial’ by King et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag109 *This podcast was generated
Episode 47 - Serious infection risk with systemic treatments for psoriasis
Episode 47 - Serious infection risk with systemic treatments for psoriasis Jul 30, 2026 4:00 In this episode of BJD Talks, Sam and Meera discuss the article ‘Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)’ by Bright et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag174 *This podcast was generated by an AI tool created by 67Bricks for the B
Episode 46 - Narrowband vs broadband UVB phototherapy for moderate-to-severe atopic dermatitis
Episode 46 - Narrowband vs broadband UVB phototherapy for moderate-to-severe atopic dermatitis Jul 23, 2026 4:02 In this episode of BJD Talks, Sam and Meera discuss the article ‘Narrowband versus broadband ultraviolet B phototherapy for adults with moderate-to-severe atopic dermatitis: a randomized controlled trial’ by Drucker et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag161 *This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologis
Episode 45 - Inflammation in recessive dystrophic epidermolysis bullosa
Episode 45 - Inflammation in recessive dystrophic epidermolysis bullosa Jul 1, 2026 3:30 In this episode of BJD Talks, Sam and Meera discuss the article ‘Systemic inflammation in recessive dystrophic epidermolysis bullosa: a 5-year longitudinal study’ by Karakioulaki et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag082 *This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*
Episode 44 - Genome-wide meta-analysis in lichen sclerosus
Episode 44 - Genome-wide meta-analysis in lichen sclerosus Jun 25, 2026 4:12 In this episode of BJD Talks, Sam and Meera discuss the article ‘Genome-wide meta-analysis in lichen sclerosus identifies 14 genomic risk loci’ by Dand et al. The full article can be accessed at https://doi.org/10.1093/bjd/ljag088*This podcast was generated by an AI tool created by 67Bricks for the British Association of Dermatologists*

Recommended